Beta-amylase from soybean (Glycine max) as a processing aid (enzyme) - 7 Dec 2020

Allergy & Anaphylaxis Australia (A&AA) made a submission to Food Standards Australia New Zealand re: Application A1204 - Beta-amylase from soybean (Glycine max) as a processing aid (enzyme).

Summary:

A&AA is not opposed to the application, but has issues and concerns which do not appear to have been fully addressed. The labelling obligation seem to be stated ambiguously and should be expressed more emphatically. The issues surrounding allergenicity, processing and digestion may need investigation in greater depth, and accordingly A&AA urges the referral of matters of allergenicity to the FSANZ Food Allergy and Intolerance Scientific Advisory Group of experts in allergic disease as a matter of routine. 

See PDF for full letter. pdfAAA re: Application A1204 - Beta-amylase from soybean (Glycine max) as a processing aid (enzyme)195.19 KB

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William


© 2023 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 



ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.